This study is part of the National Institutes of Health Rare Disease Clinical Research Network dedicated to myasthenia gravis (MGNet). The MGNet is dedicated to a better understanding of myasthenia gravis.
The MuSK 1000 study is organized at George Washington University by the MGNet research team. Henry Kaminski, MD is principal investigator for MGNet and oversees the MuSK 1000 study.